Protease-Mediated Recovery of Amnion from Placenta and Its Application as a Bioprocessed Therapeutic Biomaterial for Wound Healing
Abstract
Material and Methods: The enzymatic treatment effectively removes non-collagenous proteins and epithelial layers, creating high-quality amnion suitable for wound-healing applications. Biophysical characterization of the biomaterials demonstrated suitable tensile strength, permeability to oxygen and water vapor, and high surface area, all critical for effective wound coverage and healing.
Results: In vitro studies showed that amnion scaffolds promoted fibroblast proliferation with low toxicity and high biocompatibility, while in vivo rat models indicated significantly faster wound healing, with complete closure observed in 7 days compared to 12–14 days for controls. Histological analysis confirmed enhanced collagen organization and skin structure regeneration in treated wounds.
Conclusion: These results demonstrate that enzymatically processed amnion scaffolds are an effective and cost-efficient alternative for wound care, with superior healing outcomes compared to conventional therapies. This study supports the use of amnion-derived biomaterials in treating chronic wounds, including diabetic and venous leg ulcers.
Keywords
Full Text:
PDFReferences
Ertl J, Pichlsberger M, Tuca AC, Wurzer P, Fuchs J, Geyer SH, et al. Comparative study of regenerative effects of mesenchymal stem cells derived from placental amnion, chorion and umbilical cord on dermal wounds. Placenta 2018;65:37-46.
Zahorec P, Koller J, Danisovic L, Bohac M. Mesenchymal stem cells for chronic wounds therapy. Cell Tissue Bank 2015; 16:19-26.
Bartus CL, Margolis DJ. Reducing the incidence of foot ulceration and amputation in diabetes. Curr Diab Rep 2004;6: 413-8.
Mrugala A, Sui A, Plummer M, Altman I, Papineau E, Frandsen D, et al. Amniotic membrane is a potential regenerative option for chronic non healing wounds: a report of five cases receiving dehydrated human amnion/chorion membrane allograft. Int Wound J 2016;4:485-92.
Iversen MM, Tell GS, Riise T, Hanestad BR, Østbye T, Graue M, et al. History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trøndelag Health Study, Norway. Diabetes Care 2009;32:2193-9.
Cavanagh P, Attinger C, Abbas Z, Bal A, Rojas N, Xu ZR. Cost of treating diabetic foot ulcers in five different countries. Diabetes/metabolism research and reviews 2012;28:107-11.
Harding KG, Morris HL, Patel G. Healing chronic wounds. BMJ 2002;324:160-3.
Liu ZJ, Velazquez OC. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 2008;10:1869-82.
Reinar LM, Forsetlund L, Bjørndal A, Lockwood DN. Interventions for skin changes caused by nerve damage in leprosy. Cochrane Database Syst Rev 2008;3. doi: 10.1002/14651858. CD004833.pub4.
Das S, Baker AB. Biomaterials and nanotherapeutics for enhancing skin wound healing. Front Bioeng Biotechnol 2016; 4:82.
Rahimnejad M, Derakhshanfar S, Zhong W. Biomaterials and tissue engineering for scar management in wound care. Burns Trauma 2017;5. doi: 10.1186/s41038-017-0069-9.
Dreifke MB, Jayasuriya AA, Jayasuriya AC. Current wound healing procedures and potential care. Mater Sci Eng 2015;48: 651-62.
Penny H, Rifkah M, Weaver A, Zaki P, Young A, Meloy G, et al. Dehydrated human amnion/chorion tissue in difficult–toheal DFUs: a case series. J Wound Care 2015;24:104-11.
Sivasubramanian S, Chandrasekar G, Svensson Akusjärvi S, Thangam R, Sathuvan M, Kumar RBS, et al. Phenotypic screening identifies synergistically acting natural product enhancing the performance of biomaterial based wound healing. Front Pharmacol 2017;8:433.
Sivasubramanian S, Mohana S, Maheswari P, Victoria V, Thangam R, Mahalingam J, et al. Leprosy-associated chronic wound management using biomaterials. J Glob Infect Dis 2018; 10:99-107.
Nejad AR, Hamidieh AA, Amirkhani MA. Update review on five top clinical applications of human amniotic membrane in regenerative medicine. Placenta 2021;103:104-19.
Niknejad H, Peirovi H, Jorjani M. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cells Mater 2008;15:88-99.
Toda A, Okabe M, Yoshida T, Nikaido T. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci 2007;105:215-28.
Deferrari G, Ravera M, Berruti V. Treatment of diabetic nephropathy in its early stages. Diabetes Metab Res Rev 2003;19: 101–14.
Phiel CJ, Wilson CA, Lee VM, Klein PS. GSK-3alpha regulates production of Alzheimer’s disease amyloid-beta peptides. Nature 2003;423:435–9.
Kunitz M. Crystalline soyabean trypsin inhibitor II. General properties. J Gen Physiol 1947:30:291-310.
Zahari NK, Sheikh Ab Hamid S, Yusof N. Effects of different doses of gamma irradiation on oxygen and water vapour transmission rate of preserved human amniotic membrane. Cell Tissue Bank 2015;16:55-63.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
Dovi JV, He LK, DiPietro LA. Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 2003;73:448–55.
Fernandes LL, Resende CX, Tavares DS, Soares GA, Castro LO, Granjeiro JM. Cytocompatibility of chitosan and collagenchitosan scaffolds for tissue engineering. Polímeros 2011;21:1-6.
Aamodt JM, Grainger DW. Extracellular matrix-based biomaterial scaffolds and the host response. Biomater 2016;86:68–82.
Martin P. Wound healing--aiming for perfect skin regeneration. Science 1997;276:75-81.
Guo X, Kaplunovsky A, Zaka R, Wang C, Rana H, Turner J, et al. Modulation of cell attachment, proliferation, and angiogenesis by decellularized, dehydrated human amniotic membrane in in vitro models. Wounds 2017;29:28–38.
Sabol TJ, Tran GS, Matuszewski J, Weston WW. Standardized reporting of amnion and amnion/chorion allograft data for wound care. Health Sci Rep 2022;5:e794.
Litwiniuk M, Bikowska B, Niderla-Bielinska J, Jozwiak J, Kaminski A, Skopinski P, et al. Potential role of metalloproteinase inhibitors from radiationsterilized amnion dressings in the healing of venous leg ulcers. Mol Med Rep 2012;6:723-8.
Castellanos G, Bernabe-Garcia A, Moraleda JM, Nicolas FJ. Amniotic membrane application for the healing of chronic wounds and ulcers. Placenta 2017;59:146-53.
Varley M, Neelakantan S, Clyne T. Cell structure, stiffness and permeability of freeze-dried collagen scaffolds in dry and hydrated states. Acta Biomaterialia 2016;33:166-75.
Zaman HU, Islam JM, Khan MA, Khan RA. Physico-mechanical properties of wound dressing material and its biomedical application. J Mech Behav Biomed Mater 2011;4:1369-75.
Chattopadhyay S, Raines RT. Collagen-based biomaterials for wound healing. Biopolymers 2014;101:821-33.
Protzman NM, Mao Y, Long D, Sivalenka R, Gosiewska A, Hariri RJ, et al. Placental-derived biomaterials and their application to wound healing: a review. Bioengineering 2023;10:829.
Leonel LC, Miranda CM, Coelho TM, Ferreira GAS, Caãada RR, Miglino MA, et al. Decellularization of placentas: establishing a protocol. Braz J Med Biol Res 2017;17:51.
Hadjipanayi E, Mudera V, Brown RA. Close dependence of fibroblast proliferation on collagen scaffold matrix stiffness. J Tissue Eng Regen Med 2009;3:77-84.
Dunn L, Prosser HC, Tan JT, Vanags LZ, Ng MK, Bursill CA. Murine model of wound healing. J Vis Exp 2013. doi: 10.3791/50265.
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.